申请人:Global Blood Therapeutics, Inc.
公开号:US20160083348A1
公开(公告)日:2016-03-24
Provide herein are compounds and pharmaceutical compositions suitable as modulators of hemoglobin, methods and intermediates for their preparation, and methods for their use in treating disorders mediated by hemoglobin and disorders that would benefit from tissue and/or cellular oxygenation.
本文提供了适用于调节血红蛋白的化合物和制药组合物,它们的制备方法和中间体,以及它们在治疗由血红蛋白介导的疾病和需要组织和/或细胞氧合的疾病中的应用方法。